Neuroleptic Malignant Syndrome in a Multiple Trauma Patient.
Publication/Presentation Date
2-1-1990
Abstract
Neuroleptic malignant syndrome is a little-known adverse reaction to neuroleptic administration characterized by hyperpyrexia, leukocytosis, creatine kinase elevations, muscular rigidity, autonomic dysfunction, and alterations in level of consciousness. Neuroleptic malignant syndrome has an associated 20% mortality but can be reversed when treated with neuroleptic discontinuation and administration of bromocriptine and dantrolene. Early diagnosis in the trauma unit may prevent an extensive workup for presumed sepsis. To our knowledge, neuroleptic malignant syndrome has not previously been reported in a multiple trauma patients.
Volume
125
Issue
2
First Page
274
Last Page
275
ISSN
0004-0010
Published In/Presented At
Boorse, R. C., & Rhodes, M. (1990). Neuroleptic malignant syndrome in a multiple trauma patient. Archives Of Surgery (Chicago, Ill.: 1960), 125(2), 274-275.
Disciplines
Medicine and Health Sciences | Other Medical Specialties | Surgery | Trauma
PubMedID
2302069
Department(s)
Department of Medicine, Department of Surgery, Department of Surgery Faculty
Document Type
Article